IHS Chemical Week

World News and Views :: Projects

Lonza Expands Viral-Based Therapeutics Business with New cGMP Unit at Houston

1:53 AM MDT | May 18, 2011 | Natasha Alperowicz

Lonza says it will expand its viral-based therapeutics business with the construction of a new cGMP clean room adjacent to its existing Houston operations. The facility will offer large-scale capacity to support late-stage viral vaccine and gene therapy projects. It will use disposable process systems and be able to support production anf fill/finish operations of up to 2,000 liters. Enhanced, EU compliant, fill and finish capabilities are in high demand from Lonza's pharma and biotech customers, the company says. The expansion will also reduce Lonza's clients'...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa